{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:30:33Z","timestamp":1762993833734,"version":"3.45.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007497","name":"Biosense Webster","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007497","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.hroo.2023.11.012","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T01:37:46Z","timestamp":1700357866000},"page":"50-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sarcoid heart disease and imaging"],"prefix":"10.1016","volume":"5","author":[{"given":"Jian Liang","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory E.","family":"Supple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2023.11.012_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027971","article-title":"Pathophysiological gaps, diagnostic challenges, and uncertainties in cardiac sarcoidosis","volume":"12","author":"Ueberham","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2023.11.012_bib2","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"Drent","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hroo.2023.11.012_bib3","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.hroo.2023.11.012_bib4","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jcmg.2016.11.019","article-title":"Complementary role of CMR to conventional screening in the diagnosis and prognosis of cardiac sarcoidosis","volume":"10","author":"Kouranos","year":"2017","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.hroo.2023.11.012_bib5","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1093\/eurheartj\/ehz428","article-title":"Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries","volume":"40","author":"Ekstrom","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2023.11.012_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ejhf.1319","article-title":"Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres","volume":"20","author":"Fussner","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hroo.2023.11.012_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019415","article-title":"Manifestations and outcome of cardiac sarcoidosis and idiopathic giant cell myocarditis by 25-year nationwide cohorts","volume":"10","author":"Nordenswan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2023.11.012_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjcard.2014.11.028","article-title":"Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis","volume":"115","author":"Takaya","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib9","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ehf2.12581","article-title":"The chameleon of cardiology: cardiac sarcoidosis before and after heart transplantation","volume":"7","author":"Sedaghat-Hamedani","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hroo.2023.11.012_bib10","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.carpath.2009.04.006","article-title":"Unusual cardiovascular manifestations of sarcoidosis, a report of three cases: coronary artery aneurysm with myocardial infarction, symptomatic mitral valvular disease, and sudden death from ruptured splenic artery","volume":"19","author":"Barton","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"10.1016\/j.hroo.2023.11.012_bib11","doi-asserted-by":"crossref","first-page":"omz033","DOI":"10.1093\/omcr\/omz033","article-title":"Spontaneous coronary artery dissection in cardiac sarcoidosis","volume":"2019","author":"Kandolin","year":"2019","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.hroo.2023.11.012_bib12","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1002\/clc.20381","article-title":"Coronary sarcoidosis presenting as acute coronary syndrome","volume":"32","author":"Lam","year":"2009","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib13","first-page":"385","article-title":"Prognosis and outcomes of clinically diagnosed cardiac sarcoidosis without positive endomyocardial biopsy findings","volume":"1","author":"Kusano","year":"2021","journal-title":"JACC: Asia"},{"key":"10.1016\/j.hroo.2023.11.012_bib14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.11.012_bib15","doi-asserted-by":"crossref","first-page":"00516","DOI":"10.1183\/23120541.00516-2021","article-title":"Underdiagnosis of cardiac sarcoidosis by ECG and echocardiography in cases of extracardiac sarcoidosis","volume":"8","author":"Ohira","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.hroo.2023.11.012_bib16","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004518","article-title":"Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests","volume":"95","author":"Martusewicz-Boros","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hroo.2023.11.012_bib17","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A Multiple biomarker approach in patients with cardiac sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J"},{"key":"10.1016\/j.hroo.2023.11.012_bib18","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1378\/chest.106.4.1021","article-title":"Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis","volume":"106","author":"Suzuki","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.hroo.2023.11.012_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2023.11.012_bib21","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.hroo.2023.11.012_bib22","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.hroo.2023.11.012_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1532-429X-13-13","article-title":"T2-weighted cardiovascular magnetic resonance in acute cardiac disease","volume":"13","author":"Eitel","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.hroo.2023.11.012_bib24","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/CIRCIMAGING.113.000416","article-title":"Cardiac magnetic resonance assessment of myocarditis","volume":"6","author":"Friedrich","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2023.11.012_bib25","article-title":"T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.hroo.2023.11.012_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/radiol.213170","article-title":"Diagnostic accuracy of cardiac MRI versus FDG PET for cardiac sarcoidosis: a systematic review and meta-analysis","volume":"304","author":"Aitken","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.hroo.2023.11.012_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2023.11.012_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.hroo.2023.11.012_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.113.000867","article-title":"Evaluation of known or suspected cardiac sarcoidosis","volume":"9","author":"Blankstein","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2023.11.012_bib30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/eurheartj\/ehad067","article-title":"Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis","volume":"44","author":"Lehtonen","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hroo.2023.11.012_bib31","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/ehf2.13276","article-title":"Late gadolinium enhancement characteristics in giant cell myocarditis","volume":"8","author":"Yang","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.hroo.2023.11.012_bib32","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1016\/j.jcmg.2019.06.024","article-title":"Diagnostic specificity of basal inferoseptal triangular late gadolinium enhancement for identification of cardiac sarcoidosis","volume":"12","author":"Kuo","year":"2019","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.hroo.2023.11.012_bib33","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/heartjnl-2013-305187","article-title":"Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis","volume":"100","author":"Ise","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.hroo.2023.11.012_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.hroo.2023.11.012_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-016-0502-7","article-title":"Patient preparation for cardiac fluorine\u201318 fluorodeoxyglucose positron emission tomography imaging of inflammation","volume":"24","author":"Osborne","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib36","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jacc.2013.09.022","article-title":"Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis","volume":"63","author":"Blankstein","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib38","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s12350-017-1043-4","volume":"25","author":"Slart","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hroo.2023.11.012_bib40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","article-title":"Cardiac sarcoidosis","volume":"68","author":"Birnie","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib41","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial (18)FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.hroo.2023.11.012_bib42","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of (18)F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hroo.2023.11.012_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s12350-019-01659-2","article-title":"FDG-PET in possible cardiac sarcoidosis: right ventricular uptake and high total cardiac metabolic activity predict cardiovascular events","volume":"28","author":"Tuominen","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib44","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.222483","article-title":"Prognostic value of cardiac MRI and FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis","volume":"307","author":"Aitken","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.hroo.2023.11.012_bib45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s12350-016-0477-4","article-title":"Continuing evolution in preparation protocols for (18)FDG PET assessment of inflammatory or malignant myocardial disease","volume":"24","author":"Bois","year":"2017","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib46","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.120.046900","article-title":"Diagnostic yield of electroanatomic voltage mapping in guiding endomyocardial biopsies","volume":"142","author":"Casella","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.11.012_bib47","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1161\/CIRCULATIONAHA.107.186093","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology","volume":"116","author":"Cooper","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.11.012_bib48","first-page":"1764","article-title":"PET-driven, voltage-guided atrial endomyocardial biopsy clinches the diagnosis of cardiac sarcoidosis","volume":"3","author":"Flautt","year":"2021","journal-title":"J Am Coll Cardiol Case Rep"},{"key":"10.1016\/j.hroo.2023.11.012_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13497","article-title":"Value of 3D mapping-guided endomyocardial biopsy in cardiac sarcoidosis: case series and narrative review on the value of electro-anatomic mapping-guided endomyocardial biopsies","volume":"51","author":"Haanschoten","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.hroo.2023.11.012_bib50","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis: JACC State-of-the-Art Review","volume":"76","author":"Trivieri","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib51","first-page":"466","article-title":"Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis","volume":"2","author":"Liang","year":"2014","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.hroo.2023.11.012_bib52","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.hrthm.2017.10.035","volume":"15","author":"Al-Khatib","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2023.11.012_bib53","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCULATIONAHA.121.058120","article-title":"Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable cardioverter defibrillator","volume":"146","author":"Nordenswan","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2023.11.012_bib54","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijcard.2021.11.061","article-title":"The role of electrophysiology study in risk stratification of cardiac sarcoidosis patients: meta-analyses and systemic review","volume":"349","author":"Adhaduk","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib55","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamacardio.2021.4738","article-title":"Outcomes associated with catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"7","author":"Siontis","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib56","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1111\/jce.15708","article-title":"Outcomes of catheter ablation for ventricular tachycardia in patients with sarcoidosis: insights from the National Inpatient Sample database (2002\u20132018)","volume":"33","author":"Tan","year":"2022","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib57","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2023.11.012_bib58","first-page":"291","article-title":"Characterization of the electroanatomic substrate in cardiac sarcoidosis: correlation with imaging findings of scar and inflammation","volume":"4","author":"Muser","year":"2018","journal-title":"J Am Coll Cardiol EP"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501823003033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501823003033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:27:04Z","timestamp":1762993624000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501823003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2666501823003033"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2023.11.012","relation":{},"ISSN":["2666-5018"],"issn-type":[{"type":"print","value":"2666-5018"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoid heart disease and imaging","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2023.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}